Dara Kass, MD reposted
State-level efforts to reclassify vital medications (like mifepristone) as "controlled substances" are creating roadblocks for standard obstetric care. Professors Liz Tobin-Tyler and @darakass.com and Senior Fellow @spsaki.bsky.social describe the laws' unintended, often dangerous consequences.